Clinical trial
Steroids and Unfractionated Heparin in Critically Ill Patients With Pneumonia From COVID-19 Infection. A Multicenter, Interventional, Randomized, Three Arms Study Design
NCT04528888 is registered in ClinicalTrials.gov with Massimo Girardis as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Steroids and Unfractionated Heparin in Critically Ill Patients With Pneumonia From COVID-19 Infection. A Multicenter, Interventional, Randomized, Three Arms Study Design
- Lead sponsor
- Massimo Girardis
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- November 25, 2020
- Completion date
- July 30, 2021
- Enrollment
- 210 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
coagulopathy, covid19, pneumonia, viral, sars-cov infection